UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS — Los Angeles, California

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Clinical Trials Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS has participated in 26 clinical trials.

Therapeutic areas: Pneumonia, Pneumocystis Carinii, HIV Infections, HIV Seronegativity.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS?

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS conducted?

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS has 26 clinical trials on record. Their work covers Pneumonia, Pneumocystis Carinii, HIV Infections, HIV Seronegativity.

Is UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS accredited by Crixeo Clinical Trials?

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.